Skip to main content
. 2020 Jan 24;12(1):22–29. doi: 10.1136/flgastro-2019-101372

Table 3.

Univariate analysis comparing factors related to proactive therapeutic drug monitoring use

Variable OR 95% CI
Practice setting
 Tertiary hospital 2.25 0.8 to 6.1
 Teaching hospital 1.1 0.61 to 1.9
 Private practice 1.2 0.07 to 19.8
Grade
 Registrar (gastroenterology) 0.5 0.2 to 1.05
 IBD nurse specialist 1.2 0.7 to 2.12
Years in practice
 <1 0.83 0.18 to 3.9
 1–4 2.02 0.8 to 5.16
 5–9 2.58 1.04 to 6.4
 10–19 1.5 0.63 to 3.5
 >20 2.13 0.83 to 5.5
Per cent of patients with IBD
 11–25 4.8 0.5 to 42.8
 26–50 4.5 0.5 to 39.5
 >50 10.8 1.3 to 90.3

IBD, inflammatory bowel disease.